Association between high-sensitivity C-reactive protein and lipid profile in patients with type 2 diabetes mellitus
Keywords:
hs-CRP, lipid profile, type 2 diabetes mellitus, cardiovascular diseaseAbstract
Background: The most significant and challenging health issue of the modern era is diabetes mellitus and its complications. Inflammation plays a crucial role in the development and progression of diabetes. Type 2 Diabetes Mellitus patients(T2DM) are at significant risk of developing cardiovascular diseases. High-sensitive CRP (hs-CRP) has become a reliable indicator of low-grade inflammation. Since very little is known regarding the relationship between hs-CRP and T2DM, the goal of this study was to evaluate hs-CRP levels and lipid profile and to study their relationship to cardiovascular problems in Type 2 Diabetes Mellitus patients. Material and Methods: The current study was carried out at Index Medical College and Hospital in Indore. The study group consisted of 70 healthy controls and 70 Type 2 Diabetes Mellitus patients who had been diagnosed following WHO criteria. Serum hs-CRP concentrations as well as the lipid profile (total cholesterol, HDL, and TG) were assessed. SPSS version 26 was used to analyze the data. Results: In comparison to controls, individuals with Type 2 Diabetes Mellitus had significantly higher levels of hs-CRP, with a mean value of 2.49 + 1.15 mg/L (p <0.001).
Downloads
References
Adveetabiotech.com. [cited 2022 Jun 30]. Available from: https://adveetabiotech.com/wp-content/uploads/2020/05/21_Triglycerides-Test_Kit.pdf
AMBADE VIVEKN, SHARMA YV, SOMANI BL. Methods for estimation of blood glucose : A comparative evaluation. Medical Journal Armed Forces India. 1998;54(2):131–3.
American Diabetes association. Consensus statement: role of cardiovascular risk factors in prevention and treatment of macrovascular disease in diabetes. Diab Care.1993;16:72-78
Ana ML, Eridan S, Carol LF, Agnaluce M, Angela H, Luis A. Association between elevated serum C-reactive protein and triglyceride levels in young subjects with type 1 diabetes. Diabetes Care. 2006;29:424-6.
Archana, .-., Datta, C., & Tiwari, P. (2016). Impact of environmental degradation on human health. International Research Journal of Management, IT and Social Sciences, 3(1), 1-6. Retrieved from https://sloap.org/journals/index.php/irjmis/article/view/341
Baba MM, Balogun MO, Kolawole BA, Ikem RT, Arogundade FA, Adebayo RA. Relationship between C-reactive protein and body mass index in Nigerians with type II diabetes mellitus. Niger J Clin Med. 2012;4(3).
Baranwal JK, Maskey R, Majhi S, Lamsal M, Baral N. Association between level of HbA1c and lipid profile in T2DM patients attending diabetic OPD at BPKIHS. Health Renaissance. 2017;13(3):16-23.
Barzilay JI, Abraham L, Heckbert SR, et al..The relation of markers of inflammation to the development of glucose disorders in the elderly: the Cardiovascular Health Study. Diabetes 2001;50:2384–2389.
Bashir S, Shabbir I, Aasim M. Role of C-reactive protein as a marker for microalbuminuria in type 2 diabetics. Journal of Ayub Medical College Abbottabad. 2014;26(1):32-4.
Bhaskar S, Tarafdar HA, Kumar M, Astik SK. Study to determine the relation between HBA1C, Lipid Profile and CRP in individuals with type 2 diabetes mellitus in a tertiary care hospital. International Journal of Medical and Biomedical Studies. 2021;5(3):73–7.
Brownlee M, Cerami A, Vlassara H. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med. 1988;318:1315-21.
Burchardt P, Zurawski J, Zuchowski B, Kubacki T, Murawa D, Wiktorowicz K, et al. Low-density lipoprotein, its susceptibility to oxidation and the role of lipoprotein-associated phospholipase A2 and carboxyl ester lipase lipases in atherosclerotic plaque formation. Arch Med Sci 2013;9:151-158.
COBAS-6000 [Internet]. Full text of "cobas 6000 sop pdf". [cited 2022Jul16]. Available from: https://archive.org/stream/Cobas6000SOPPdf/Cobas-6000-SOP-pdf_djvu.txt Guest. Insert.c.f.a.s. proteins.12104938001.v8.en [Internet]. pdfcoffee.com.
Determining the association between HbA1C, Lipid profile and CRP in individuals with type 2 diabetes mellitus: an observational study. European Journal of Molecular & Clinical Medicine, 2021; 7(10): 3504-3510.
Diagnosis and classification of diabetes mellitus. (2010). Diabetes Care, 33(Supplement_1), 62–69. https://doi.org/10.2337/dc10-s062
Doraickannu T, Sechassayana T, Vithiavathi S, Varisali M. Study of highly sensitive C-reactive protein in type 2 diabetes mellitus and prediction of cardiovascular risk with glycemic status. International Journal of Advances in Medicine. 2019;6(3):687–90.
Duncan B, Schmidt M, Pankow J, Ballantyne C. Atherosclerosis risk in communities study. Lowgrade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diab. 2003;52:1799-05.
Ebrahimi M, Heidari-Bakavoli AR, Shoeibi S, Mirhafez SR, Moohebati M, Esmaily H, et al. Association of serum HS-CRP levels with the presence of obesity, diabetes mellitus, and other cardiovascular risk factors. Journal of Clinical Laboratory Analysis. 2016;30(5):672–6.
Effoe VS, Correa A, Chen H, Lacy ME, Bertoni AG. High-sensitivity C-reactive protein is associated with incident type 2 diabetes among African Americans: The Jackson Heart Study. Diabetes Care. 2015;38(9):1694–700.
Faggad A, Dongway A, Zaki H, Abdalla B. C-reactive protein is associated with low-density lipoprotein cholesterol and obesity in type 2 diabetic Sudanese. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2015;427-435.
Festa A, D’Agostino R Jr, Tracy RP,Haffner SM: Elevated levels of acute phase proteins and plasminogen activator inhibitor-1 predict the development of type 2 diabetes: the Insulin Resistance Atherosclerosis Study. Diabetes 2002;51(3):1131–1137.
Forbes JM, Cooper ME. Mechanisms of diabetic complications. Physiological Reviews. 2013;93(1):137–88.
Furukawa S, Fujita T, Shimabukuro M, et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest. 2004;114(12):1752–1761.
Global report on diabetes [Internet]. World Health Organization. World Health Organization; [cited 2022Jul16]. Available from: https://www.who.int/publications-detail-redirect/9789241565257.
Hayashino Y, Mashitani T, Tsujii S, Ishii H. Serum high-sensitivity C-reactive protein levels are associated with high risk of development, not progression, of diabetic nephropathy among Japanese type 2 diabetic patients: a prospective cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT7]). Diabetes Care. 2014;37(11):2947-52.
HDL [Internet]. Biotec. 2018 [cited 2022Jul16]. Available from: https://www.biotec-co.com/images/products/clinical_chemistry/kits/chemistry/HDL%20CHOLESTEROL.pdf.
HDL Cholesterol precipitating reagent set [Internet]. Biopacific.net. [cited 2022 Jun Available from: http://www.biopacific.net/wp-content/uploads/2016/07/Pointe-HDL-Cholesterol-PEG-Insert.pdf
Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing type 2 diabetes in women. Diabetes.2004;53:693–700 .
Huffman FG, Whisner S, Zarini GG, Nath S. Waist circumference and BMI in relation to serum high sensitivity C-reactive protein (hs-CRP) in Cuban Americans with and without type 2 diabetes. Int J Environ Res Public Health. 2010;7(3):842–852.
Ikeda K, Higashi T, Sano H, Jinnouchi Y, Yoshida M, Araki T, et al. N ε- (carboxymethyl) lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochem. 1996;35(24):8075-83.
Jaiswal A, Tabassum R, Podder A, Ghosh S, Tandon N, Bharadwaj D. Elevated level of C-reactive protein is associated with risk of Prediabetes in Indians. Atherosclerosis. 2012;222(2):495–501.
Kitada M, Zhang Z, Mima A, King GL. Molecular mechanisms of diabetic vascular complications. Journal of Diabetes Investigation. 2010;1(3):77–89.
Kitsios K, Papadopoulou M, Kosta K, Kadoglou N, Papagianni M, Tsiroukidou K.High-sensitivity C-reactive protein levels and metabolic disorders in obese and overweight children and adolescents. J Clin Res Pediatr Endocrinol.2013;5:44-49
Koley S, et al. Association of Lipid Profile Parameters with High-Sensitive C-reactiveProtein (hsCRP) in Patients with Dyslipidemia. Ann Med Health Sci Res. 2018;8:105-107.
Krishnaveni P, Gowda VM. Assessing the validity of Friedewald’s Formula and anandraja’s formula for serum LDL-cholesterol calculation. J Clin Diagn Res [Internet]. 2015;9(12):BC01-4. Available from: http://dx.doi.org/10.7860/JCDR/2015/16850.6870.
Laaksonen DE, Niskanen L, Nyyssonen K et al. Creactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 2004; 47(1): 1403-10.
Meriga RK, Nareddy VA, Sudha Sai Bhavya SV, Sreekeerthi C. Correlation between glycemic control, lipid profile and C-reactive protein in adults with type 2 diabetes mellitus done in a tertiary care hospital of Nellore, Andhra Pradesh, India. International Journal of Advances in Medicine. 2020;7(9):1312–8.
Mojahedi MJ, Bonakdaran S, Hami M, Sheikhian MR, Shakeri MT, Aiatollahi H. Elevated serum C-reactive protein level and microalbuminuria in patients with type 2 diabetes mellitus. Iran J Kidney Dis. 2009;3(1):12-6.
Moreira TS, Hamadeh MJ. The role of vitamin D deficiency in the pathogenesis of type 2 diabetes mellitus. e-SPEN, the European e-Journal of Clinical Nutrition and Metabolism. 2010;5(4):e155-e65
Nakanishi S, Yamane K, Kamei N, Okubo M, Kohno N. Elevated C-reactive protein is a risk factor for the development of type 2 diabetes in Japanese Americans. Diabetes Care.2003;26:2754–2757.
PDFCOFFEE.COM; [cited 2022Jul16]. Available from: https://pdfcoffee.com/download/insertcfas-proteins12104938001v8en-pdf-free.html
Pfützner A, Forst T. High-sensitivity C-reactive protein as cardiovascular risk marker in patients with diabetes mellitus. Diabetes Technology & Therapeutics. 2006;8(1):28–36.
Reddy S, Bichler J, Wells-Knecht KJ, Thorpe SR, Baynes JW. N. epsilon-(carboxymethyl) lysine is a dominant advanced glycation end product (AGE) antigen in tissue proteins. Biochem. 1995;34(34):10872-8.
Roberts WL. CDC/AHA workshop on markers of inflammation and cardiovascular disease. Circulation. 2004Dec21;110(25):572–6.
S S R, M M B, Y S S. A study of high sensitivity C–reactive protein (HSCRP) in relation to HbA1C in type2 diabetes mellitus in tertiary care hospital, Mysore. International Journal of Contemporary Medicine, Surgery and Radiology. 2019;4(1): A62-A64.
Slowinska-Solnica K, Pawlica-Gosiewska D, Gawlik K, Kuzniewski M, Maziarz B, Solnica B. High Performance Liquid chromatography accurately measures hba1c also inpatients with end-stage renal disease - performance evaluation of the A1C HPLC analyzer. Clinical Laboratory. 2018;64(9):1451-1455.
Stehouwer CDA, Gall M-A, Twisk JWR, Knudsen E, Emeis JJ, Parving H-H. Increased urinary albumin excretion, endothelial dysfunction, and chronic low-grade inflammation in type 2 diabetes. Diabetes. 2002;51(4):1157–65.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2022). Post-pandemic health and its sustainability: Educational situation. International Journal of Health Sciences, 6(1), i-v. https://doi.org/10.53730/ijhs.v6n1.5949
Thorand B, Löwel H, Schneider A, Kolb H, Meisinger C, Fröhlich M, et al. C- reactive protein as a predictor for incident diabetes mellitus among middle-aged men. Archives of Internal Medicine. 2003;163(1):93.
Tutuncu Y, Satman I, Celik S, Dinccag N, Karsidag K, Telci A, et al. A comparison of HS-CRP levels in new diabetes groups diagnosed based on FPG, 2-HPG, or hba1c criteria. Journal of Diabetes Research. 2016;2016(2016):1–9.
Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. Jama. 1999;282:2131-2135.
Waheed P, Naveed AK, Farooq F. Levels of inflammatory markers and their correlation with dyslipidemia in diabetics. J Coll Physicians Surg Pak. 2009;19(4):207-10.
Widana, I. K., Sumetri, N. W., & Sutapa, I. K. (2018). Effect of improvement on work attitudes and work environment on decreasing occupational pain. International Journal of Life Sciences, 2(3), 86–97. https://doi.org/10.29332/ijls.v2n3.209
Williams MJ, Williams SM, Milne BJ, Hancox RJ, Poulton R. Association between C-reactive protein, metabolic cardiovascular risk factors, obesity and oral contraceptive use in young adults. Inter J Obes. 2004;28:998-1003.
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
